- Home
- SCNI vs BENF Comparison
SCNI vs BENF Comparison
Compare SCNI & BENF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- BENF
- Stock Information
- Founded
- SCNI 2003
- BENF 2003
- Country
- SCNI Israel
- BENF United States
- Employees
- SCNI N/A
- BENF N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- BENF Blank Checks
- Sector
- SCNI Health Care
- BENF Finance
- Exchange
- SCNI Nasdaq
- BENF Nasdaq
- Market Cap
- SCNI 3.2M
- BENF 2.6M
- IPO Year
- SCNI N/A
- BENF N/A
- Fundamental
- Price
- SCNI $2.47
- BENF $0.30
- Analyst Decision
- SCNI
- BENF
- Analyst Count
- SCNI 0
- BENF 0
- Target Price
- SCNI N/A
- BENF N/A
- AVG Volume (30 Days)
- SCNI 1.1M
- BENF 2.6M
- Earning Date
- SCNI 08-14-2025
- BENF 08-13-2025
- Dividend Yield
- SCNI N/A
- BENF N/A
- EPS Growth
- SCNI N/A
- BENF N/A
- EPS
- SCNI N/A
- BENF N/A
- Revenue
- SCNI $658,000.00
- BENF N/A
- Revenue This Year
- SCNI N/A
- BENF N/A
- Revenue Next Year
- SCNI N/A
- BENF N/A
- P/E Ratio
- SCNI N/A
- BENF N/A
- Revenue Growth
- SCNI N/A
- BENF N/A
- 52 Week Low
- SCNI $1.90
- BENF $0.22
- 52 Week High
- SCNI $8.92
- BENF $6.27
- Technical
- Relative Strength Index (RSI)
- SCNI 49.52
- BENF 44.42
- Support Level
- SCNI $2.15
- BENF $0.26
- Resistance Level
- SCNI $2.70
- BENF $0.30
- Average True Range (ATR)
- SCNI 0.22
- BENF 0.03
- MACD
- SCNI 0.01
- BENF -0.00
- Stochastic Oscillator
- SCNI 32.99
- BENF 34.52
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.
About BENF Beneficient
Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and an innovative financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.